Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Gavrilov

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Israel Medical Association Journal : IMAJ|May 11, 2002
Deliberate self-poisoning in adolescentsMatityahu Lifshitz, Vladimir Gavrilov
Anticancer Research|August 17, 2005
The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growthVladimir Gavrilov, Michael Steiner, Shraga Shany
American Journal of Hematology|October 31, 2003
Urinary excretion of retinol in patients with multiple myeloma: a preliminary studyVladimir Gavrilov, Tikva Yermiahu, Rafael Gorodischer
Anticancer Research|November 5, 2014
Sodium valproate, a histone deacetylase inhibitor, enhances the efficacy of vinorelbine-cisplatin-based chemoradiation in non-small cell lung cancer cellsVladimir Gavrilov, Konstantin Lavrenkov, Samuel Ariad, et al.
Renal Failure|November 6, 2004
Urinary excretion of vitamin A in critically ill patients complicated with acute renal failureVladimir Gavrilov, Natan Weksler, Ahmed Ahmed, et al.
The Journal of Pharmacy and Pharmacology|August 9, 2003
Transdermal delivery of paracetamol for paediatric use: effects of vehicle formulations on the percutaneous penetrationAmnon C Sintov, Igor Krymberk, Vladimir Gavrilov, et al.
In Vivo (Athens, Greece)|April 18, 2007
Efficient dual treatment of the hormone-refractory prostate cancer cell line DU145 with cetuximab and 1,25-dihydroxyvitamin D3Olga Belochitski, Samuel Ariad, Shraga Shany, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 11, 2010
A combined pretreatment of 1,25-dihydroxyvitamin D3 and sodium valproate enhances the damaging effect of ionizing radiation on prostate cancer cellsVladimir Gavrilov, Yaron Leibovich, Samuel Ariad, et al.
Current Therapeutic Research, Clinical and Experimental|June 20, 2014
Unapproved prescriptions in two pediatric intensive care units in IsraelVladimir Gavrilov, Matityahu Berkovitch, Galina Ling, et al.
Acta Diabetologica|June 21, 2011
Kidney function and retinol status in type 2 diabetes mellitus patientsVladimir Gavrilov, Ilana Harman-Boehm, Doron Amichay, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Israel Medical Association Journal : IMAJ|May 11, 2002
Deliberate self-poisoning in adolescentsMatityahu Lifshitz, Vladimir Gavrilov
Anticancer Research|August 17, 2005
The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growthVladimir Gavrilov, Michael Steiner, Shraga Shany
American Journal of Hematology|October 31, 2003
Urinary excretion of retinol in patients with multiple myeloma: a preliminary studyVladimir Gavrilov, Tikva Yermiahu, Rafael Gorodischer
Anticancer Research|November 5, 2014
Sodium valproate, a histone deacetylase inhibitor, enhances the efficacy of vinorelbine-cisplatin-based chemoradiation in non-small cell lung cancer cellsVladimir Gavrilov, Konstantin Lavrenkov, Samuel Ariad, et al.
Renal Failure|November 6, 2004
Urinary excretion of vitamin A in critically ill patients complicated with acute renal failureVladimir Gavrilov, Natan Weksler, Ahmed Ahmed, et al.
The Journal of Pharmacy and Pharmacology|August 9, 2003
Transdermal delivery of paracetamol for paediatric use: effects of vehicle formulations on the percutaneous penetrationAmnon C Sintov, Igor Krymberk, Vladimir Gavrilov, et al.
In Vivo (Athens, Greece)|April 18, 2007
Efficient dual treatment of the hormone-refractory prostate cancer cell line DU145 with cetuximab and 1,25-dihydroxyvitamin D3Olga Belochitski, Samuel Ariad, Shraga Shany, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 11, 2010
A combined pretreatment of 1,25-dihydroxyvitamin D3 and sodium valproate enhances the damaging effect of ionizing radiation on prostate cancer cellsVladimir Gavrilov, Yaron Leibovich, Samuel Ariad, et al.
Current Therapeutic Research, Clinical and Experimental|June 20, 2014
Unapproved prescriptions in two pediatric intensive care units in IsraelVladimir Gavrilov, Matityahu Berkovitch, Galina Ling, et al.
Acta Diabetologica|June 21, 2011
Kidney function and retinol status in type 2 diabetes mellitus patientsVladimir Gavrilov, Ilana Harman-Boehm, Doron Amichay, et al.
Pageof 2